Ev3 Inc. Settles Suits Over $2.6B Covidien Merger
Medical device maker ev3 Inc. has agreed to settle several proposed shareholder class actions filed over its proposed $2.6 billion sale to Ireland's Covidien PLC....To view the full article, register now.
Already a subscriber? Click here to view full article